Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery

Eli I Lev1, Mahesh Ramchandani, Rajeev Garg

  • 1Department of Cardiology, The Methodist Hospital Research Institute, The Methodist DeBakey Heart Center, Houston, TX 77030, USA.

Insights

Low response to aspirin is linked to poor clopidogrel response in patients undergoing cardiovascular surgery. This suggests a potential need for personalized antiplatelet therapy in this group.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Previous studies linked low platelet response to aspirin with clopidogrel non-response in percutaneous coronary intervention patients.
  • The relationship between aspirin and clopidogrel response in patients undergoing major cardiovascular surgery remained unclear.

Purpose of the Study:

  • To investigate the association between aspirin and clopidogrel response in patients scheduled for cardiac or vascular surgery.
  • To determine if low response to one antiplatelet agent predicts low response to the other in this surgical cohort.

Main Methods:

  • 100 patients scheduled for cardiac/vascular surgery on aspirin and clopidogrel were analyzed.
  • Platelet function was assessed using the modified TEG platelet mapping assay (ADP, AA) and PFA-100 assay (CEPI, CADP).
  • Low response was defined as < or =20% inhibition for TEG-ADP or TEG-AA.

Main Results:

  • 13% of patients were low responders to aspirin and 34% to clopidogrel.
  • Eight patients exhibited low response to both aspirin and clopidogrel.
  • Aspirin low responders showed significantly lower TEG-ADP inhibition (P=0.03) and a trend towards lower PFA-CADP time (P=0.1).
  • Clopidogrel low responders demonstrated significantly lower TEG-AA inhibition (P=0.01) and a trend towards lower PFA-CEPI time (P=0.07).

Conclusions:

  • Low response to aspirin is significantly associated with low response to clopidogrel in patients undergoing cardiovascular surgery.
  • These findings highlight a potential link between antiplatelet drug response across different agents in surgical patients.
  • Further research may explore implications for perioperative antiplatelet management.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...